malignant melanoma

You have access
Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of Cancer
CARSTEN NIEDER, SIV GYDA AANES and ELLINOR C. HAUKLAND

Anticancer Research June 2022, 42 (6) 3061-3066; DOI: https://doi.org/10.21873/anticanres.15793
You have access
Nivolumab for the Treatment of Advanced Pediatric Malignancies
AGATA MARJAŃSKA, MONIKA DROGOSIEWICZ, BOŻENNA DEMBOWSKA-BAGIŃSKA, KATARZYNA PAWIŃSKA-WĄSIKOWSKA, WALENTYNA BALWIERZ, KATARZYNA BOBEFF, WOJCIECH MŁYNARSKI, AGNIESZKA MIZIA-MALARZ, ANNA RACIBORSKA, MARIUSZ WYSOCKI and JAN STYCZYŃSKI

Anticancer Research December 2020, 40 (12) 7095-7100; DOI: https://doi.org/10.21873/anticanres.14738
You have access
Melanoma Risk Estimation Based on Objective Measures as a Complement to Self-Assessment
ADAM CARLSSON and MAGNUS FALK

Anticancer Research June 2020, 40 (6) 3325-3331; DOI: https://doi.org/10.21873/anticanres.14315
You have access
National Comprehensive Analysis of Characteristics of Acral Lentiginous Melanoma
MARIA T. HUAYLLANI, DAVID J. RESTREPO, DANIEL BOCZAR, FRANCISCO R. AVILA, SANJAY P. BAGARIA, AARON C. SPAULDING, BRIAN D. RINKER and ANTONIO J. FORTE

Anticancer Research June 2020, 40 (6) 3411-3415; DOI: https://doi.org/10.21873/anticanres.14325
You have access
Association of Vitamin D Receptor Gene Polymorphisms With Melanoma Risk: A Meta-analysis and Systematic Review
MICHELLE BIRKE, JAKOB SCHÖPE, STEFAN WAGENPFEIL, THOMAS VOGT and JÖRG REICHRATH

Anticancer Research February 2020, 40 (2) 583-595; DOI: https://doi.org/10.21873/anticanres.13988
You have access
Efficacy and Toxicity of Pembrolizumab in Pediatric Metastatic Recurrent Melanoma
AGATA MARJANSKA, PRZEMYSLAW GALAZKA, MICHAL MARJANSKI, MARIUSZ WYSOCKI and JAN STYCZYNSKI

Anticancer Research July 2019, 39 (7) 3945-3947; DOI: https://doi.org/10.21873/anticanres.13547
You have access
Hyperthermia Suppresses Post - In Vitro Proliferation and Tumor Growth in Murine Malignant Melanoma and Colon Carcinoma
THEODORA MANTSO, STAVROS VASILEIADIS, EVANGELI LAMPRI, SOTIRIS BOTAITIS, SEBACHEDIN PERENTE, CONSTANTINOS SIMOPOULOS, KATERINA CHLICHLIA, AGLAIA PAPPA and MIHALIS I. PANAYIOTIDIS

Anticancer Research May 2019, 39 (5) 2307-2315; DOI: https://doi.org/10.21873/anticanres.13347
You have access
Comparison of Diagnosis-specific Survival Scores for Patients With Cerebral Metastases from Malignant Melanoma Including the New WBRT-30-MM
DIRK RADES, LENA SEHMISCH, HEINKE C. HANSEN, LIESA DZIGGEL, STEFAN JANSSEN and STEVEN E. SCHILD

Anticancer Research March 2019, 39 (3) 1501-1505; DOI: https://doi.org/10.21873/anticanres.13268
You have access
Isothiocyanate-induced Cell Cycle Arrest in a Novel In Vitro Exposure Protocol of Human Malignant Melanoma (A375) Cells
THEODORA MANTSO, IOANNIS ANESTOPOULOS, ELEFTHERIA LAMPRIANIDOU, IOANNIS KOTSIANIDIS, AGLAIA PAPPA and MIHALIS I. PANAYIOTIDIS

Anticancer Research February 2019, 39 (2) 591-596; DOI: https://doi.org/10.21873/anticanres.13152
You have access
Analysis of Malignant Melanoma Cell Lines Exposed to Hypoxia Reveals the Importance of PFKFB4 Overexpression for Disease Progression
SONIA E. TROJAN, MONIKA PIWOWAR, BARBARA OSTROWSKA, PIOTR LAIDLER and KINGA A. KOCEMBA-PILARCZYK

Anticancer Research December 2018, 38 (12) 6745-6752; DOI: https://doi.org/10.21873/anticanres.13044

Main menu

User menu

Search

malignant melanoma

Pages